Andrew Hykes - 01 Oct 2024 Form 4 Insider Report for Inari Medical, Inc.

Role
President and CEO, Director
Signature
/s/ Shannon Trevino, attorney-in-fact for Andrew Hykes
Issuer symbol
N/A
Transactions as of
01 Oct 2024
Net transactions value
-$171,540
Form type
4
Filing time
03 Oct 2024, 16:36:41 UTC
Previous filing
22 Aug 2024
Next filing
31 Oct 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NARI Common Stock Tax liability $20,640 -508 -0.11% $40.63 452,024 01 Oct 2024 Direct F1
transaction NARI Common Stock Tax liability $38,477 -947 -0.21% $40.63 451,077 01 Oct 2024 Direct F2
transaction NARI Common Stock Tax liability $59,929 -1,475 -0.33% $40.63 449,602 01 Oct 2024 Direct F3
transaction NARI Common Stock Tax liability $52,494 -1,292 -0.29% $40.63 448,310 01 Oct 2024 Direct F4
holding NARI Common Stock 1,550 01 Oct 2024 By Child 1
holding NARI Common Stock 1,550 01 Oct 2024 By Child 2
holding NARI Common Stock 1,550 01 Oct 2024 By Child 3
holding NARI Common Stock 1,000 01 Oct 2024 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2021.
F2 Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2022.
F3 Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2023.
F4 Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2024.